Mar 9, 2019

Practices to anonymize data often reveal a lot of detail about individuals

Illustration: Sarah Grillo/Axios

Most data brokers avoid scrutiny by saying the data they collect and sell is “anonymized,” or a summary of a lot of people's information, rather than a single individual’s data.

Yes, but: That "anonymous" data can be used to pinpoint real people, or match that data to other supposedly anonymous profiles.

  • In 2006, AOL released search histories of 657,000 anonymous Americans, hoping the data could spur new research. But those searches contained things like locations, ages and genders — ultimately linkable back to specific people.
  • Researchers like Latanya Sweeney have discovered a variety of other ways to reverse more subtle forms of information. In fact, most Americans can be identified by birthday, gender and zip code, she discovered when she led Harvard’s Data Privacy Lab.
  • Last year, researchers noticed that hashing email addresses — thought to be an anonymizing mathematical function that would turn email addresses into gibberish — could be reversed by taking lists of leaked email addresses and performing trial and error searches.
“Once released, information is hard to control. Thus, over time, the more information and data can be linked and analyzed, the higher the likelihood of being able to make sensitive inferences from it for larger groups of people."
— Alessandro Acquisti, a Carnegie Mellon Professor who has studied re-identification

Go deeper

The global scramble to contain the coronavirus

Taking precaution, in the Philippines. Photo: Ezra Acayan/Getty Images

The coronavirus is spreading quickly in cities nowhere near Wuhan, China, and the window to prevent a global pandemic is narrowing.

Zoom in: Here's a look at what comes with a coronavirus outbreak in communities outside China that have been hardest hit so far.

Go deeperArrow10 mins ago - World

Experimental coronavirus vaccine to be tested on humans

Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. Photo: Win McNamee/Getty Images

The vaccine that the National Institute of Allergy and Infectious Diseases (NIAID) and drugmaker Moderna have been developing to combat the coronavirus is ready to be tested on humans, NIAID director Anthony Fauci told the Wall Street Journal.

The state of play: The rapidly developed vaccine will be tested on 20–25 healthy volunteers in April to determine whether two doses will be safe and generate an immune response to protect against infection. Results will be available in July or August, Fauci told WSJ.

Go deeperArrow2 hours ago - Health